ArticleBiomedical optics express2026
Multimodal optical system for quantitative discrimination of bilirubin species.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multimodal Optical Biosensing for Precision Medicine and Healthcare: Introduction to the feature issue.Biomedical optics express · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bilirubin occurs in human serum in multiple molecular forms: free unconjugated, albumin-bound, and conjugated species, and distinguishing between them is clinically relevant for assessing liver function and bilirubin metabolism. However, current routine assays do not resolve these subtypes individually. Here, we present a compact, multimodal optical platform that combines absorbance spectroscopy, fluorescence intensity, fluorescence anisotropy, and photobleaching analysis to investigate the optical signatures of bilirubin species in solution. Using well-defined synthetic standards representing free, bound, and conjugated bilirubin, we characterize each modality's discriminative capability. Absorbance measurements enable total bilirubin determination, fluorescence provides high sensitivity to albumin-bound bilirubin, and anisotropy measurements, done with a plate reader, reveal different responses to each species through their differing rotational mobilities. Photobleaching kinetics further highlight species-dependent photostability under controlled irradiance conditions. Taken together, these complementary, label-free optical readouts enable improved resolution of bilirubin subtypes in synthetic samples and establish a foundation for future translational studies in biologically complex matrices.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.